交銀國際:上調瑞聲科技(2018.HK)目標價至80港元 評級“買入”
交銀國際發佈報告稱,瑞聲科技(2018.HK)盈利將同比顯著復甦,將目標價由原來65港元升至80港元,升幅達23%,維持“買入”評級。
該行預計,瑞聲科技2019及2020年每股盈利預測提高2%及7%,主要由於鏡頭毛利率改善、iPhone需求穩定、安卓聲學產品均價相對於去年的下降,在今年表現較穩定,以及盈利同比基數低,預計今年第一季度開始,瑞聲科技的盈利將同比顯著復甦。
該行還稱,大立光電面臨產能緊張,利好瑞聲二線塑料鏡片製造商在中端市場獲得份額,預計今年混合鏡頭的採用率將會提高,這將帶動提高塑料鏡片利潤率。

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.